AMERICAN CHEMICAL SOCIETY With the coronavirus pandemic temporarily shuttering hair salons, many clients are appreciating, and missing, the ability of hair dye to cover up grays or touch up roots. However, frequent coloring, whether done at a salon or at home, can damage hair and might pose health risks from potentially cancer-causing dye components. Now,...
by Elena Merenda and Nikki Martyn, The Conversation Children may be struggling with feelings of abandonment and a loss of security in their lives. Credit: Shutterstock COVID-19 has taken the world by storm and profoundly changed the lives of children and families. Children aren’t going to school and many businesses have temporarily shut down. Many...
With politicians touting the potential benefits of malaria drugs to fight COVID-19, some people are turning away from clinical trials of other therapies. People with COVID-19 who arrive at the Salvador Zubirán National Institute of Medical Sciences and Nutrition in Mexico City to search for treatment can choose from a menu of clinical trials, carefully...
Antibody-based therapies can be used to protect at-risk populations, including medical workers, from the virus. The race to develop effective antibody-based treatments for COVID-19 is advancing at a rapid pace. Now, a Tel Aviv University laboratory reports it has successfully isolated two antibodies that would neutralize the virus’s ability to infect human cells. The two...
The head of the maker of remdesivir, an anti-viral shown to reduce recovery times in COVID-19 patients, said Sunday the company has been exporting the drug and is making it available to patients in the United States through the US government. Gilead Sciences CEO Daniel O’Day said the company is donating its entire existing supply...
by Judith Graham, Kaiser Health News Older adults with COVID-19, the illness caused by the coronavirus, have several “atypical” symptoms, complicating efforts to ensure they get timely and appropriate treatment, according to physicians. COVID-19 is typically signaled by three symptoms: a fever, an insistent cough and shortness of breath. But older adults—the age group most...
By JENNIFER SMITH FOR DAILYMAIL.COM Researchers in San Francisco and some in Massachusetts studied 14 different antibody tests Among them, only three returned results that were more than 99% specific in detecting antibodies One test, made by Sure Biotech which is registered in both the US and Hong Kong, had a 100% accuracy rate The...
US Secretary of State Mike Pompeo said last fortnight that India and the US were working together to develop vaccines against the coronavirus. Mr Pompeo’s remark didn’t entirely come as a surprise. The two countries have run an internationally recognised joint vaccine development programme for more than three decades. They have worked on stopping dengue,...
By Sally Robertson, B.Sc Researchers at the Indian Institute of Technology, Guwahati, have made an important discovery about a viral fusion protein found on the surface of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could help researchers develop a vaccine. Their finding that a mutation in the protein’s cleavage site disrupts binding to host...
Eight ways in which scientists hope to provide immunity to SARS-CoV-2 . More than 90 vaccines are being developed against SARS-CoV-2 by research teams in companies and universities across the world. Researchers are trialling different technologies, some of which haven’t been used in a licensed vaccine before. At least six groups have already begun injecting...
